SHILPAMED2026-04-232026-04-23SHILPAMED2026-04-23SHILPAMED2026-04-23

ChangeInManagementDomain1

SHILPAMED2026-04-232026-04-23

ChangeInManagementDomain1

xbrli:pure

SHILPAMED

SHILPA MEDICARE LIMITED

530549

NOTLISTED

INE790G01031

true

Listed Entity (self)

false

2026-04-22

08:50:00

2026-04-23

Appointment

Senior Management Personnel

COO

Mr.

Vellaian Karuppiah

2026-04-23

Dr. Vellaian Karuppiah aged 52 years, brings over 33 years of extensive and diverse experience across the pharmaceutical value chain with deep expertise spanning Formulation & Analytical R&D, Regulatory Affairs, Manufacturing Science & Technology (MS&T), Technology Transfer, Engineering & Projects, Quality Systems, EHS/ESG, Supply Chain Management, PPIC, and end-to-end Manufacturing Operations. He has held senior leadership and C-suite positions in several globally reputed pharmaceutical organizations including Gland Pharma Limited (Fosun Group), Strides Group, Dr. Reddy’s Laboratories, Actavis (now Teva), Orchid Healthcare (Hospira/Pfizer), amongst few others. His career reflects strong global exposure and cross-functional leadership, with a consistent track record in driving operational excellence, regulatory compliance, and business transformation initiatives. In his recent roles as Chief Operating Officer at Acme Group and Immacule Lifesciences, Dr. Karuppiah has been instrumental in strengthening manufacturing efficiency, supply chain resilience, quality systems, and R&D integration, thereby contributing significantly to organizational growth and competitiveness. Dr. Vellaian Karuppiah holds a Postgraduate degree and Doctorate in Pharmacy, along with Executive Management qualifications from premier Tier-1 institutions in India and abroad. Given his proven leadership capabilities, strategic orientation, and rich industry experience, his appointment is expected to significantly strengthen the Company’s Formulation business operations, enhance operational efficiencies, and support long-term sustainable growth.